{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:49:53Z","timestamp":1788058193563,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jhin.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:33:56Z","timestamp":1699972436000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study"],"prefix":"10.1016","volume":"143","author":[{"given":"I.","family":"Savarese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yazami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.U.","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Carkeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Auriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Danhaive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Piersigilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2023.11.003_bib1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/cid\/cir138","article-title":"Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O'Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.11.003_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7326\/0003-4819-142-6-200503150-00011","article-title":"Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection","volume":"142","author":"Safdar","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhin.2023.11.003_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1941874413476043","article-title":"Intravascular catheter-related bloodstream infection","volume":"3","author":"Shah","year":"2013","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jhin.2023.11.003_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1067\/mpd.2002.122499","article-title":"A\u00a0national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States","volume":"140","author":"Grohskopf","year":"2002","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhin.2023.11.003_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3345\/kjp.2018.07003","article-title":"Central line-associated bloodstream infections in neonates","volume":"62","author":"Cho","year":"2019","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.jhin.2023.11.003_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00431-020-03844-9","article-title":"How to minimize central line-associated bloodstream infections in a neonatal intensive care unit: a quality improvement intervention based on a retrospective analysis and the adoption of an evidence-based bundle","volume":"180","author":"Bierlaire","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jhin.2023.11.003_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1469-0691.2002.00388.x","article-title":"The antibiotic-lock technique for therapy of 'highly needed' infected catheters","volume":"8","author":"Carratala","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib8","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/AAC.46.6.1674-1679.2002","article-title":"Antimicrobial activity of a novel catheter lock solution","volume":"46","author":"Shah","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2023.11.003_bib9","article-title":"Treatment of long-term catheter-related bloodstream infections with short-course Daptomycin lock and systemic therapy associated with taurolidine-lock: a multicenter experience","author":"Vassallo","year":"2023","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.jhin.2023.11.003_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/11297298211026453","article-title":"Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients","volume":"24","author":"Brescia","year":"2023","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.jhin.2023.11.003_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/apt.14904","article-title":"Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition","volume":"48","author":"Wouters","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhin.2023.11.003_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2021.10.022","article-title":"The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis","volume":"123","author":"van den Bosch","year":"2022","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.2363","article-title":"Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition","volume":"46","author":"Vernon-Roberts","year":"2022","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jhin.2023.11.003_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/jpc.14506","article-title":"Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates","volume":"56","author":"Chong","year":"2020","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jhin.2023.11.003_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MPG.0000000000003658","article-title":"Systematic review of antimicrobial lock solutions for prevention of bacteremia in pediatric patients with intestinal failure","volume":"76","author":"Gibson","year":"2023","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhin.2023.11.003_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhin.2021.09.013","article-title":"Catheter lock solutions for reducing catheter-related bloodstream infections in paediatric patients: a network meta-analysis","volume":"118","author":"Guo","year":"2021","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/1129729821990215","article-title":"Mindful organizing as a healthcare strategy to decrease catheter-associated infections in neonatal and pediatric intensive care units. A systematic review and grading recommendations (GRADE) system","volume":"22","author":"Rosati","year":"2021","journal-title":"J\u00a0Vasc Access"},{"issue":"Suppl 1","key":"10.1016\/j.jhin.2023.11.003_bib18","first-page":"S59","article-title":"The prevention, diagnosis and management of central venous line infections in children","volume":"71","author":"Chesshyre","year":"2015","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib19","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1542\/peds.106.5.e63","article-title":"Should central venous catheters be removed as soon as candidemia is detected in neonates?","volume":"106","author":"Karlowicz","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhin.2023.11.003_bib20","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1542\/peds.111.3.e269","article-title":"Central venous catheter removal versus in situ treatment in neonates with enterobacteriaceae bacteremia","volume":"111","author":"Nazemi","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhin.2023.11.003_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jhin.2018.01.004","article-title":"Clinical impact of delayed catheter removal for patients with central-venous-catheter-related Gram-negative bacteraemia","volume":"99","author":"Lee","year":"2018","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib22","doi-asserted-by":"crossref","first-page":"a010306","DOI":"10.1101\/cshperspect.a010306","article-title":"Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era","volume":"3","author":"Kostakioti","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhin.2023.11.003_bib23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","article-title":"Microbial biofilms","volume":"49","author":"Costerton","year":"1995","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jhin.2023.11.003_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/antibiotics12020352","article-title":"Antibiotic resistance and biofilm infections in the nicus and methods to combat it","volume":"12","author":"Baltogianni","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jhin.2023.11.003_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhin.2023.11.003_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijantimicag.2009.06.020","article-title":"Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis","volume":"34","author":"Del Pozo","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2023.11.003_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10096-009-0831-4","article-title":"Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children","volume":"29","author":"Megged","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhin.2023.11.003_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/INF.0000000000000116","article-title":"Antifungal lock therapy with combined 70% ethanol and micafungin in a critically ill infant","volume":"33","author":"Piersigilli","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhin.2023.11.003_bib29","first-page":"614","article-title":"Use of meropenem and other antimicrobial lock therapy in the treatment of catheter-related blood stream infections in neonates: a retrospective study","volume":"9","author":"Piersigilli","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jhin.2023.11.003_bib30","first-page":"CD010336","article-title":"Antibiotic lock for the prevention of catheter-related infection in neonates","volume":"6","author":"Taylor","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhin.2023.11.003_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.clp.2021.03.009","article-title":"Antibiotic stewardship for the neonatologist and perinatologist","volume":"48","author":"Katz","year":"2021","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.jhin.2023.11.003_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jhin.2019.04.022","article-title":"Effects of prophylactic use of taurolidine-citrate lock on the number of catheter-related infections in children under 2 years of age undergoing surgery","volume":"103","author":"Lyszkowska","year":"2019","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3945\/ajcn.117.158964","article-title":"Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial","volume":"106","author":"Tribler","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhin.2023.11.003_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clnu.2014.01.010","article-title":"Recurrent catheter related bloodstream infections by Candida glabrata: successful treatment with taurolidine","volume":"33","author":"Diamanti","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhin.2023.11.003_bib35","doi-asserted-by":"crossref","first-page":"e01521","DOI":"10.1128\/AAC.01521-19","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial (TAURCAT Study) of citrate lock solution for prevention of endoluminal central venous catheter infection in neutropenic hematological patients","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2023.11.003_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jmii.2012.04.002","article-title":"Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine","volume":"46","author":"Hartel","year":"2013","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jhin.2023.11.003_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2672.1976.tb00647.x","article-title":"Taurolin, a new chemotherapeutic agent","volume":"41","author":"Browne","year":"1976","journal-title":"J\u00a0Appl Bacteriol"},{"key":"10.1016\/j.jhin.2023.11.003_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.clnu.2014.04.023","article-title":"Microbiocidal effects of various taurolidine containing catheter lock solutions","volume":"34","author":"Olthof","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhin.2023.11.003_bib39","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/AAC.44.6.1720-1724.2000","article-title":"Activities of taurolidine in\u00a0vitro and in experimental enterococcal endocarditis","volume":"44","author":"Torres-Viera","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2023.11.003_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/0091270007299929","article-title":"The pharmacokinetics of taurolidine metabolites in healthy volunteers","volume":"47","author":"Gong","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jhin.2023.11.003_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008927","article-title":"Taurolidine antiadhesive properties on interaction with E.\u00a0coli; its transformation in biological environment and interaction with bacteria cell wall","volume":"5","author":"Caruso","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2023.11.003_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2125.1981.tb01245.x","article-title":"The characterisation and quantitation by high-performance liquid chromatography of the metabolites of taurolin","volume":"12","author":"Knight","year":"1981","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123003699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123003699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:23:33Z","timestamp":1759292613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670123003699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":42,"alternative-id":["S0195670123003699"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2023.11.003","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}